Duloxetine 60/120 mg Versus Placebo in the Treatment of Fibromyalgia Syndrome

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-001524-37

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

to assess the efficacy of duloxetine 60/120mg once daily (QD) compared with placebo on the treatment of pain in patients with American College of Rheumatology (ACR) defined primary fibromyalgia syndrome (FMS), with or without major depressive disorder (MDD), during the 6-month, acute therapy phase of the study.


Critère d'inclusion

  • fibromyalgia syndrome